Migraine and risk of cardiovascular disease in women: prospective cohort study

English version České info

Objective:
To evaluate the association between migraine and incident cardiovascular disease and cardiovascular mortality in women.

Design:
Prospective cohort study among Nurses’ Health Study II participants, with follow-up from 1989 and through June 2011.

Setting:
Cohort of female nurses in United States.

Participants:
115 541 women aged 25-42 years at baseline and free of angina and cardiovascular disease. Cumulative follow-up rates were more than 90%.

Main outcome measures:
The primary outcome of the study was major cardiovascular disease, a combined endpoint of myocardial infarction, stroke, or fatal cardiovascular disease. Secondary outcome measures included individual endpoints of myocardial infarction, stroke, angina/coronary revascularization procedures, and cardiovascular mortality.

Results:
17 531 (15.2%) women reported a physician’s diagnosis of migraine. Over 20 years of follow-up, 1329 major cardiovascular disease events occurred and 223 women died from cardiovascular disease. After adjustment for potential confounding factors, migraine was associated with an increased risk for major cardiovascular disease (hazard ratio 1.50, 95% confidence interval 1.33 to 1.69), myocardial infarction (1.39, 1.18 to 1.64), stroke (1.62, 1.37 to 1.92), and angina/coronary revascularization procedures (1.73, 1.29 to 2.32), compared with women without migraine. Furthermore, migraine was associated with a significantly increased risk for cardiovascular disease mortality (hazard ratio 1.37, 1.02 to 1.83). Associations were similar across subgroups of women, including by age (<50/≥50), smoking status (current/past/never), hypertension (yes/no), postmenopausal hormone therapy (current/not current), and oral contraceptive use (current/not current).

Conclusions:
Results of this large, prospective cohort study in women with more than 20 years of follow-up indicate a consistent link between migraine and cardiovascular disease events, including cardiovascular mortality. Women with migraine should be evaluated for their vascular risk. Future targeted research is warranted to identify preventive strategies to reduce the risk of future cardiovascular disease among patients with migraine.

Autoři: Tobias Kurth ^1,2,3; Anke C Winter ⁴; A. Heather Eliassen ^3,5; Rimma Dushkes ¹; Kenneth J Mukamal; Eric B Rimm ^3,5,6; Walter C Willett ^3,6; Joann E Manson ^1,3,5; Kathryn M Rexrode ¹
Působiště autorů: Institute of Public Health, Charité - Universitätsmedizin, D-10117 Berlin, Germany ¹; Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA ²; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA ³; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, Saint Louis, MO, USA ⁴; Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA ⁵; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA ⁶
Vyšlo v časopise: BMJ 2016, 353:i2610
Kategorie: Research
prolekare.web.journal.doi_sk: https://doi.org/10.1136/bmj.i2610

© 2016 BMJ Publishing Group Ltd
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

Souhrn

Objective:
To evaluate the association between migraine and incident cardiovascular disease and cardiovascular mortality in women.

Design:
Prospective cohort study among Nurses’ Health Study II participants, with follow-up from 1989 and through June 2011.

Setting:
Cohort of female nurses in United States.

Participants:
115 541 women aged 25-42 years at baseline and free of angina and cardiovascular disease. Cumulative follow-up rates were more than 90%.

Zdroje

1 Stovner Lj, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210. doi:10.1111/j.1468-2982.2007.01288.x.

2 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808. doi:10.1177/0333102413485658.

3 Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 2015;55:21-34. doi:10.1111/head.12482.

4 Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated metaanalysis. Am J Med 2010;123:612-24. doi:10.1016/j.amjmed.2009.12.021.

5 Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A. Migraine and hemorrhagic stroke: a meta-analysis. Stroke 2013;44:3032-8. doi:10.1161/STROKEAHA.113.002465.

6 Kurth T, Chabriat H, Bousser M-G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012;11:92-100. doi:10.1016/S1474-4422(11)70266-6.

7 Mawet J, Kurth T, Ayata C. Migraine and stroke: in search of shared mechanisms. Cephalalgia 2015;35:165-81. doi:10.1177/0333102414550106.

8 Napoli R, Guardasole V, Zarra E, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009;72:2111-4. doi:10.1212/WNL.0b013e3181aa53ce.

9 Liman TG, Bachelier-Walenta K, Neeb L, et al. Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia 2015;35:88-94. doi:10.1177/0333102414529671.

10 Tietjen GE, Al-Qasmi MM, Athanas K, Utley C, Herial NA. Altered hemostasis in migraineurs studied with a dynamic flow system. Thromb Res 2007;119:217-22. doi:10.1016/j.thromres.2005.12.020.

11 Scher AI, Terwindt GM, Picavet HSJ, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-20. doi:10.1212/01.WNL.0000151857.43225.49.

12 Malik R, Freilinger T, Winsvold BS, et al. International Headache Genetics Consortium METASTROKE Collaboration of the International Stroke Genetics Consortium. Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology 2015;84:2132-45. doi:10.1212/WNL.0000000000001606.

13 Schürks M, Buring JE, Ridker PM, Chasman DI, Kurth T. Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One 2011;6:e22106. doi:10.1371/journal.pone.0022106.

14 Eikermann-Haerter K. Spreading depolarization may link migraine and stroke. Headache 2014;54:1146-57. doi:10.1111/head.12386.

15 Dreier JP, Reiffurth C. The stroke-migraine depolarization continuum. Neuron 2015;86:902-22. doi:10.1016/j.neuron.2015.04.004.

16 Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005;64(Suppl 2):S9-15. doi:10.1212/WNL.64.10_ suppl_2.S9.

17 Longoni M, Ferrarese C. Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 2006;27(Suppl 2):S107-10. doi:10.1007/s10072-006-0582-2.

18 Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-91. doi:10.1001/jama.296.3.283.

19 Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010;74:628-35. doi:10.1212/WNL.0b013e3181d0cc8b.

20 Wang Y-C, Lin C-W, Ho Y-T, Huang YP, Pan SL. Increased risk of ischemic heart disease in young patients with migraine: a population-based, propensity score-matched, longitudinal follow-up study. Int J Cardiol 2014;172:213-6. doi:10.1016/j.ijcard.2014.01.005.

21 Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010;341:c3966. doi:10.1136/bmj.c3966.

22 Schürks M, Buring JE, Kurth T. Agreement of self-reported migraine with ICHD-II criteria in the Women’s Health Study. Cephalalgia 2009;29:1086-90. doi:10.1111/j.1468-2982.2008.01835.x.

23 Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol 1984;119:837-9.

24 Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular survey methods.World Health Organization, 1982.

25 Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke 1981;12(Suppl 1):I13-44.

26 Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007;167:795-801. doi:10.1001/archinte.167.8.795.

27 Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the american heart association. Circulation 2011;123:1243-62. doi:10.1161/CIR.0b013e31820faaf8.

28 Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914. doi:10.1136/bmj.b3914.

29 Sternfeld B, Stang P, Sidney S. Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology 1995;45:2135-42. doi:10.1212/WNL.45.12.2135.

30 Rose KM, Carson AP, Sanford CP, et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 2004;63:2233-9. doi:10.1212/01.WNL.0000147289.50605.DC.

31 Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975;231:718-22. doi:10.1001/jama.1975.03240190022010.

32 Tzourio C, Tehindrazanarivelo A, Iglésias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830-3. doi:10.1136/bmj.310.6983.830.

33 MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007;38:2438-45. doi:10.1161/STROKEAHA.107.488395.

34 Kurth T, Schürks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008;337:a636. doi:10.1136/bmj.a636.

35 Liman TG, Neeb L, Rosinski J, et al. Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study. Cephalalgia 2012;32:459-66. doi:10.1177/0333102412444014.

36 González-Quintanilla V, Toriello M, Palacio E, et al. Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator. Cephalalgia 2016;36:552-60. doi:10.1177/0333102415607857.

37 Totaro R, Marini C, De Matteis G, Di Napoli M, Carolei A. Cerebrovascular reactivity in migraine during headache-free intervals. Cephalalgia 1997;17:191-4. doi:10.1046/j.1468-2982.1997.1703191.x.

38 Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007;68:1563-70. doi:10.1212/01.wnl.0000260964.28393.ed.

39 Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology 2007;68:1694-700. doi:10.1212/01.wnl.0000261916.42871.05.

40 Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537-42. doi:10.1212/WNL.53.3.537.

41 Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57. doi:10.1046/j.1526-4610.2001.041007646.x.

42 Buettner C, Burstein R. Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study. Cephalalgia 2015;35:757-66. doi:10.1177/0333102414559733.

43 Buettner C, Nir R-R, Bertisch SM, et al. Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol 2015;78:970-81. doi:10.1002/ana.24534.